BDBM50165945 CHEMBL371394::N-Benzyloxy-3-[(S)-2-(4,5-diphenyl-oxazol-2-yl)-cyclohex-2-enylmethyl]-benzamide

SMILES O=C(NOCc1ccccc1)c1cccc(C[C@@H]2CCCC=C2c2nc(c(o2)-c2ccccc2)-c2ccccc2)c1

InChI Key InChIKey=ZCWNNMZVVGSKSY-UHFFFAOYSA-N

Data  8 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 8 hits for monomerid = 50165945   

TargetProstaglandin E2 receptor EP4 subtype(Human)
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50165945(N-Benzyloxy-3-[(S)-2-(4,5-diphenyl-oxazol-2-yl)-cy...)
Affinity DataKi:  0.680nMAssay Description:Inhibition of [3H]PGE-2 binding to human prostanoid EP4 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetThromboxane A2 receptor(Human)
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50165945(N-Benzyloxy-3-[(S)-2-(4,5-diphenyl-oxazol-2-yl)-cy...)
Affinity DataKi: >1.00E+3nMAssay Description:Inhibition of [3H]SQ-29,548 binding to human prostanoid TP receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProstaglandin D2 receptor(Human)
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50165945(N-Benzyloxy-3-[(S)-2-(4,5-diphenyl-oxazol-2-yl)-cy...)
Affinity DataKi: >1.00E+3nMAssay Description:Inhibition of [3H]PGD-2 binding to human prostanoid DP receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProstaglandin F2-alpha receptor(Human)
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50165945(N-Benzyloxy-3-[(S)-2-(4,5-diphenyl-oxazol-2-yl)-cy...)
Affinity DataKi: >1.00E+3nMAssay Description:Inhibition of [3H]PGF-2 binding to human prostanoid FP receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProstaglandin E2 receptor EP1 subtype(Human)
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50165945(N-Benzyloxy-3-[(S)-2-(4,5-diphenyl-oxazol-2-yl)-cy...)
Affinity DataKi: >3.00E+3nMAssay Description:Inhibition of [3H]-PGE-2 binding to human prostanoid EP1 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProstaglandin E2 receptor EP2 subtype(Human)
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50165945(N-Benzyloxy-3-[(S)-2-(4,5-diphenyl-oxazol-2-yl)-cy...)
Affinity DataKi: >3.00E+3nMAssay Description:Inhibition of [3H]PGE-2 binding to human prostanoid EP2 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProstaglandin E2 receptor EP3 subtype(Human)
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50165945(N-Benzyloxy-3-[(S)-2-(4,5-diphenyl-oxazol-2-yl)-cy...)
Affinity DataKi: >3.00E+3nMAssay Description:Inhibition of [3H]PGE-2 binding to human prostanoid EP3 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProstacyclin receptor(Human)
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50165945(N-Benzyloxy-3-[(S)-2-(4,5-diphenyl-oxazol-2-yl)-cy...)
Affinity DataKi: >3.00E+3nMAssay Description:Inhibition of [3H]iloprost binding to human prostanoid IP receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed